Table 6.

Investigator's assessment of haemostatic efficacy per bleeding event during the 12-month on-demand and prophylactic treatment periods

	On-demand (N = 8)				Prophylaxis (N = 8)
		Number (%) of NSB events				Number (%) of NSB events
Bleeding type	n	Excellent	Good	Moderate	n	Excellent	Good	Moderate
All bleedings	304	299 (98.4)	5 (1.6)	0	10	10 (100.0)	0	0
Spontaneous	301	296 (98.3)	5 (1.7)	0	10	10 (100.0)	0	0
Trauma	2	2 (100.0)	0	0	0	0	0	0
Postsurgery	1	1 (100.0)	0	0	0	0	0	0
Major	116	114 (98.3)	2 (1.7)	0	3	3 (100.0)	0	0
Minor	188	185 (98.4)	3 (1.6)	0	7	7 (100.0)	0	0
Joint	99	97 (98.0)	2 (2.0)	0	2	2 (100.0)	0	0
Mucosal	191	188 (98.4)	3 (1.6)	0	8	8 (100.0)	0	0
Muscle	16	16 (100.0)	0	0	0	0	0	0

n, number of bleeding events; N, total number of study participants; NSB, nonsurgical bleeding. Note: Bleedings with missing investigator's assessment for efficacy and those for which no treatment was needed are not included